RNA

Total RNA was prepared from cell line WM1819. WM1819 is a human melanoma cell line that displays mesenchymal morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM1819 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1819. WM1819 is a human melanoma cell line that displays mesenchymal morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM1819 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1852. WM1852 is a metastatic human melanoma cell line that displays mesenchymal and spherical morphology. These cells require 10% media to adhere to culture dish. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM1852 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1852. WM1852 is a metastatic human melanoma cell line that displays mesenchymal and spherical morphology. These cells require 10% media to adhere to culture dish. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM1852 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1852. WM1852 is a metastatic human melanoma cell line that displays mesenchymal and spherical morphology. These cells require 10% media to adhere to culture dish. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM1852 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1862. WM1862 is a non-tumorigenic (RGP) primary human melanoma cell line without metastatic capability. This cell line displays pigmented, mesenchymal and spherical morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. These cells expresses wild type N-RAS, c-KIT, and CDK4. WM1862 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1862. WM1862 is a non-tumorigenic (RGP) primary human melanoma cell line without metastatic capability. This cell line displays pigmented, mesenchymal and spherical morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. These cells expresses wild type N-RAS, c-KIT, and CDK4. WM1862 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1862. WM1862 is a non-tumorigenic (RGP) primary human melanoma cell line without metastatic capability. This cell line displays pigmented, mesenchymal and spherical morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. These cells expresses wild type N-RAS, c-KIT, and CDK4. WM1862 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM1960. WM1960 is a metastatic human melanoma cell line. This cell line contains a Q61K mutation at position 61 in the N-RAS gene which causes increased signaling via the extracellular signal-regulated MAPK/ERK kinase pathways to enhance proliferation. WM1960 cells are from same patient as WM2013 and WM3060. WM1960 cells produce xenograft tumors when injected into immunocompromised mice.